메뉴 건너뛰기
European Urology
Volumn 63, Issue 4, 2013, Pages 653-654
Metastatic renal cell carcinoma: An invincible enemy?
Author keywords

[No Author keywords available]
Indexed keywords

SORAFENIB; SUNITINIB;
EID: 84874508387     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.09.060     Document Type: Editorial
Times cited : (7)
References (10)
  • 2
    • 20644463482 scopus 로고    scopus 로고
    • Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma
    • H.-S. Hofmann, H. Neef, K. Krohe, P. Andreev, and R.-E. Silber Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma Eur Urol 48 2005 77 82
    • (2005) Eur Urol , vol.48 , pp. 77-82
    • Hofmann, H.-S.1    Neef, H.2    Krohe, K.3    Andreev, P.4    Silber, R.-E.5
  • 4
    • 0036895290 scopus 로고    scopus 로고
    • Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma
    • A. Zisman, A.J. Pantuck, and J. Wieder Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559 4566
    • (2002) J Clin Oncol , vol.20 , pp. 4559-4566
    • Zisman, A.1    Pantuck, A.J.2    Wieder, J.3
  • 5
    • 68949145218 scopus 로고    scopus 로고
    • Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
    • R.J. Motzer, T.E. Hutson, and P. Tomczak Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J Clin Oncol 27 2009 3584 3590
    • (2009) J Clin Oncol , vol.27 , pp. 3584-3590
    • Motzer, R.J.1    Hutson, T.E.2    Tomczak, P.3
  • 6
    • 70249097380 scopus 로고    scopus 로고
    • Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial
    • B. Escudier, T. Eisen, and W.M. Stadler Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial J Clin Oncol 27 2009 3312 3318
    • (2009) J Clin Oncol , vol.27 , pp. 3312-3318
    • Escudier, B.1    Eisen, T.2    Stadler, W.M.3
  • 7
    • 80052263465 scopus 로고    scopus 로고
    • ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of metastatic disease
    • J.J. Patard, G. Pignot, and B. Escudier ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease Eur Urol 60 2011 684 690
    • (2011) Eur Urol , vol.60 , pp. 684-690
    • Patard, J.J.1    Pignot, G.2    Escudier, B.3
  • 8
    • 79953848961 scopus 로고    scopus 로고
    • Survival after complete surgical resection of multiple metastases from renal cell carcinoma
    • A.L. Alt, S. Boorjian, C.M. Lohse, B.A. Costello, B.C. Leibovich, and M.L. Blute Survival after complete surgical resection of multiple metastases from renal cell carcinoma Cancer 117 2011 2873 2882
    • (2011) Cancer , vol.117 , pp. 2873-2882
    • Alt, A.L.1    Boorjian, S.2    Lohse, C.M.3    Costello, B.A.4    Leibovich, B.C.5    Blute, M.L.6
  • 9
    • 84874520619 scopus 로고    scopus 로고
    • Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma
    • L. Tosco, H. Van Poppel, B. Frea, G. Gregoraci, and S. Joniau Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma Eur Urol 63 2013 646 652
    • (2013) Eur Urol , vol.63 , pp. 646-652
    • Tosco, L.1    Van Poppel, H.2    Frea, B.3    Gregoraci, G.4    Joniau, S.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.